Your Doctor Asked How Much You Drink. Then Almost Nobody Said Anything.
A new study in Addiction finds 69% of adults in care get screened for alcohol, but only 3.5% of heavy drinkers hear a word of advice about it. Women hear it least.
You know the form. It’s on a clipboard or a tablet in the waiting room, somewhere between the allergy list and the question about seatbelts: How often do you have a drink containing alcohol? How many drinks on a typical day? You round down a little. Or you tell the truth, the whole ugly number, and you brace for the conversation. And then the doctor walks in and talks about your blood pressure.
That silence isn’t an accident. It’s the system working exactly as designed: screening without a second step.
Researchers at RTI International, using federal survey data on more than 139,000 adults, published the numbers this month in Addiction. Nearly 69% of adults who saw a health-care provider were screened for alcohol use. Among adults who reported heavy drinking, 3.5% got advice from a provider to cut back. Among adults who met the criteria for alcohol use disorder, 7.5% got any alcohol treatment in the past year. Women were about 48% less likely than men to get that brief conversation and about 38% less likely to be referred to treatment. “Screening alone is not enough,” said RTI’s Katherine Karriker-Jaffe. Health economist Carolina Barbosa called each skipped conversation “a missed chance to act before an alcohol use disorder develops.”
The psychology here matters more than the billing codes. For a lot of people, the moment you write down a true number is a small act of courage, the first time you’ve let the drinking be visible to anyone with authority. When nothing comes back, people don’t conclude the doctor was busy. They conclude it must not be that bad. Silence from a clinician reads as permission. And for women, who are already more likely to drink alone and hide it, being asked and then ignored at a higher rate is its own message.
If that’s been you: the number you wrote down was real even if nobody responded to it. You’re allowed to bring it up yourself, and you’re allowed to ask directly about medications. Naltrexone and acamprosate have been FDA-approved for alcohol use disorder for decades and are prescribed to a small fraction of the people who could use them; the VA has just started recruiting veterans at 18 medical centers for a placebo-controlled trial of semaglutide for drinking, too. More in our alcohol coverage.
If you’re a clinician, the fix is one sentence long, and this week is a fine time to make it a team rule: every positive alcohol screen gets a spoken response before the patient leaves the room, even if it’s only “That’s more than what’s safe for your body, and I’d like to help you cut back. Can we talk about it?”
Somebody asked. The person who answered deserves an answer back.
Sources Cited
- 01.A
- 02.B
- 03.BVA trial to study effects of GLP-1s for alcohol use disorder among veteransBaylor College of Medicine
Filed Under
psychologytreatmentpolicyAlcoholThe Treatment GapStigmaPeer-Reviewed ResearchGovernment DataVeterans
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
Eight in Ten People in a New Study Had Recently Used Alone. Their Reasons Deserve a Better Answer Than 'Don't.'
A Substance Use and Misuse study of 493 people who use drugs found 81% had recently used alone, often for comfort and safety. What that means for overdose prevention.
Lived Experience & CommunityNearly Half of Recreational Cannabis Users Trust the Person at the Counter First. Four Percent Pick a Doctor.
A federally funded survey of 1,023 adults who used THC found dispensary staff the most trusted information source, ahead of friends and healthcare providers. What it means for clinicians.
Lived Experience & Community"Being Sober Is Payment Enough." Why a Gift Card Works on Meth Anyway
A woman in a Maine rewards program said sobriety was payment enough. Why contingency management still works for meth and cocaine, what stimulant craving and flat, joyless weeks feel like, and what the evidence does and does not prove.